Cargando…

Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases

Choline kinase (ChoK) is a cytosolic enzyme that catalyzes the phosphorylation of choline to form phosphorylcholine (PCho) in the presence of ATP and magnesium. ChoK is required for the synthesis of key membrane phospholipids and is involved in malignant transformation in a large variety of human tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lacal, Juan Carlos, Zimmerman, Tahl, Campos, Joaquín M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226952/
https://www.ncbi.nlm.nih.gov/pubmed/34070409
http://dx.doi.org/10.3390/pharmaceutics13060788
_version_ 1783712409779699712
author Lacal, Juan Carlos
Zimmerman, Tahl
Campos, Joaquín M.
author_facet Lacal, Juan Carlos
Zimmerman, Tahl
Campos, Joaquín M.
author_sort Lacal, Juan Carlos
collection PubMed
description Choline kinase (ChoK) is a cytosolic enzyme that catalyzes the phosphorylation of choline to form phosphorylcholine (PCho) in the presence of ATP and magnesium. ChoK is required for the synthesis of key membrane phospholipids and is involved in malignant transformation in a large variety of human tumours. Active compounds against ChoK have been identified and proposed as antitumor agents. The ChoK inhibitory and antiproliferative activities of symmetrical bispyridinium and bisquinolinium compounds have been defined using quantitative structure–activity relationships (QSARs) and structural parameters. The design strategy followed in the development of the most active molecules is presented. The selective anticancer activity of these structures is also described. One promising anticancer compound has even entered clinical trials. Recently, ChoKα inhibitors have also been proposed as a novel therapeutic approach against parasites, rheumatoid arthritis, inflammatory processes, and pathogenic bacteria. The evidence for ChoKα as a novel drug target for approaches in precision medicine is discussed.
format Online
Article
Text
id pubmed-8226952
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82269522021-06-26 Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases Lacal, Juan Carlos Zimmerman, Tahl Campos, Joaquín M. Pharmaceutics Review Choline kinase (ChoK) is a cytosolic enzyme that catalyzes the phosphorylation of choline to form phosphorylcholine (PCho) in the presence of ATP and magnesium. ChoK is required for the synthesis of key membrane phospholipids and is involved in malignant transformation in a large variety of human tumours. Active compounds against ChoK have been identified and proposed as antitumor agents. The ChoK inhibitory and antiproliferative activities of symmetrical bispyridinium and bisquinolinium compounds have been defined using quantitative structure–activity relationships (QSARs) and structural parameters. The design strategy followed in the development of the most active molecules is presented. The selective anticancer activity of these structures is also described. One promising anticancer compound has even entered clinical trials. Recently, ChoKα inhibitors have also been proposed as a novel therapeutic approach against parasites, rheumatoid arthritis, inflammatory processes, and pathogenic bacteria. The evidence for ChoKα as a novel drug target for approaches in precision medicine is discussed. MDPI 2021-05-25 /pmc/articles/PMC8226952/ /pubmed/34070409 http://dx.doi.org/10.3390/pharmaceutics13060788 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Lacal, Juan Carlos
Zimmerman, Tahl
Campos, Joaquín M.
Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases
title Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases
title_full Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases
title_fullStr Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases
title_full_unstemmed Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases
title_short Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases
title_sort choline kinase: an unexpected journey for a precision medicine strategy in human diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226952/
https://www.ncbi.nlm.nih.gov/pubmed/34070409
http://dx.doi.org/10.3390/pharmaceutics13060788
work_keys_str_mv AT lacaljuancarlos cholinekinaseanunexpectedjourneyforaprecisionmedicinestrategyinhumandiseases
AT zimmermantahl cholinekinaseanunexpectedjourneyforaprecisionmedicinestrategyinhumandiseases
AT camposjoaquinm cholinekinaseanunexpectedjourneyforaprecisionmedicinestrategyinhumandiseases